Monday, October 3, 2016

Breakthrough lung cancer drug made available on NHS

… suitable for patients with non-small-cell lung cancer who have a specific mutation … of EGFR T790M mutation-positive non-small-cell lung cancer, and very welcome news for … executive of the Roy Castle Lung Cancer Foundation, said: "Osimertinib represents …

No comments:

Post a Comment